PYRIMETHAMINE LEUCOVORIN capsule

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

PYRIMETHAMINE (UNII: Z3614QOX8W) (PYRIMETHAMINE - UNII:Z3614QOX8W), LEUCOVORIN CALCIUM (UNII: RPR1R4C0P4) (LEUCOVORIN - UNII:Q573I9DVLP)

Available from:

ImprimisRx PA, Inc. d/b/a ImprimisRx

INN (International Name):

PYRIMETHAMINE

Composition:

PYRIMETHAMINE 12.5 mg

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Authorization status:

unapproved drug other

Summary of Product characteristics

PYRIMETHAMINE LEUCOVORIN- PYRIMETHAMINE LEUCOVORIN CAPSULE
IMPRIMISRX PA, INC. D/B/A IMPRIMISRX
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
PYRIMETHAMINE LEUCOVORIN (12.5MG-2.5MG)
PYRIMETHAMINE LEUCOVORIN (12.5MG-2.5MG)
PYRIMETHAMINE LEUCOVORIN
pyrimethamine leucovorin capsule
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:70 271-430
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
PYRIMETHAMINE (UNII: Z36 14QOX8 W) (PYRIMETHAMINE - UNII:Z36 14QOX8 W)
PYRIMETHAMINE
12.5 mg
LEUCO VO RIN CALCIUM (UNII: RPR1R4C0 P4) (LEUCOVORIN - UNII:Q573I9
DVLP)
LEUCOVORIN
2.5 mg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
ImprimisRx PA, Inc. d/b/a ImprimisRx
CELLULO SE, MICRO CRYSTALLINE (UNII: OP1R32D6 1U)
10 0 mg
PRODUCT CHARACTERISTICS
COLOR
pink, blue
S CORE
no sco re
S HAP E
c a psule
S IZ E
15mm
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:70 271-430 -0 1
10 0 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
11/27/20 15
LABELER -
ImprimisRx PA, Inc. d/b/a ImprimisRx (080044737)
Revised: 11/2015